Phase II Study of IMRT With SIB as Adjuvant Treatment for High Risk Resected Well-differentiated Thyroid Cancer.

Clinical trial NCT00279721 · COMPLETED

Trial details

NCT number: NCT00279721
Sponsor: Alberta Health services
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Thyroid Neoplasms

Start date: 2006-01-01
Primary completion: 2010-06-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.